Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes.

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol (2000) 16.47

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol (2000) 3.54

Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 2.71

A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med (2000) 2.71

Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem (2003) 2.60

Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J (2006) 1.81

Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J (2001) 1.63

Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem (2001) 1.53

Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem (2001) 1.39

Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem (2002) 1.33

Coronary heart disease in Indians: implications of the INTERHEART study. Indian J Med Res (2010) 1.12

Ischemia modified albumin: A novel marker for acute coronary syndrome. Indian J Clin Biochem (2006) 1.10

Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol (2004) 1.09

Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ (2005) 1.08

Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J (2010) 1.00

Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol (2008) 0.96

Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem (2004) 0.94

The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J (2006) 0.94

Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta (2007) 0.91

Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med (2010) 0.87

The ischemia-modified albumin biomarker for myocardial ischemia. MLO Med Lab Obs (2003) 0.87

Biochemical markers of cardiac damage: from efficiency to effectiveness. Clin Chim Acta (2001) 0.85

Combinatorial Determination of Ischemia Modified Albumin and Protein Carbonyl in the Diagnosis of NonST-Elevation Myocardial Infarction. Indian J Clin Biochem (2011) 0.81

Missed acute cardiac ischemia in the ED: limitations of diagnostic testing. Am J Emerg Med (2004) 0.79

[New perspectives in the diagnostic approach to acute coronary syndrome]. Recenti Prog Med (2005) 0.78